• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

Introduction to 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine (CAS No. 1805012-66-1)

4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine (CAS No. 1805012-66-1) is a multifunctional compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds potential applications in the development of novel therapeutic agents and as a valuable intermediate in organic synthesis.

The molecular structure of 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine is composed of a pyridine ring substituted with an amino group, a bromine atom, a chlorine atom, and a difluoromethyl group. The presence of these functional groups imparts distinct chemical properties and reactivity profiles, making it an attractive candidate for various chemical transformations and biological studies.

In recent years, the exploration of halogenated pyridines has been a focal point in the design and synthesis of new drugs. The bromine and chlorine substituents in 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine can significantly influence the compound's pharmacokinetic properties, such as solubility, metabolic stability, and bioavailability. These factors are crucial for optimizing drug candidates for clinical trials.

The difluoromethyl group in 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine is particularly noteworthy due to its ability to enhance the lipophilicity and metabolic stability of the molecule. Fluorinated compounds often exhibit improved binding affinities to target proteins, which can lead to enhanced biological activity and reduced off-target effects. This makes 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine a promising scaffold for the development of selective and potent therapeutic agents.

Research into the biological activities of 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine has revealed its potential as an inhibitor of specific enzymes and receptors. For instance, studies have shown that this compound can effectively inhibit certain kinases involved in cancer cell proliferation, making it a potential lead compound for anticancer drug development. Additionally, its ability to modulate G protein-coupled receptors (GPCRs) has been explored in the context of treating neurological disorders.

The synthetic accessibility of 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine is another factor that contributes to its appeal in pharmaceutical research. Various synthetic routes have been developed to efficiently produce this compound, allowing for its large-scale synthesis and further optimization. These synthetic methods often involve multistep reactions that incorporate halogenation, fluorination, and functional group transformations, highlighting the versatility of this compound as a building block in organic synthesis.

In conclusion, 4-Amino-2-bromo-3-chloro-5-(difluoromethyl)pyridine (CAS No. 1805012-66-1) represents a valuable molecule with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and versatile chemical properties make it an attractive candidate for the development of novel therapeutic agents. Ongoing research continues to uncover new applications and optimize its use in various biological systems, underscoring its importance in advancing the field of drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)